Natural product-based therapy for Idiopathic pulmonary fibrosis: Hyperoside, found in Drosera Rotundifolia and Prunella vulgaris (Common self-heal), increases TRF1 expression and ameliorates pulmonary fibrosis via upregulation of its target gene, 24/October/2015, 10.29 pm

Molecular therapy for Myocardial Infarction: NGFI-B nuclear orphan receptor Nurr1 improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 24/October/2016, 10.13 pm
October 24, 2016
Natural product therapy for tuberculosis: γ-Bisabolene, one of the components in Cardamom, Cubeb, lemon, Oregano, among others, increases the expression of MKP-1, inhibits TLR2 signalling, secretion of Chemokine CXCL5, and recruitment of polymorphonuclear leukocytes (PMNs), decreases destructive pulmonary inflammation, promotes M. tuberculosis clearance and inhibits pulmonary tuberculosis via up-regulation of its target gene, 24/October/2016, 10.46 pm
October 24, 2016
Show all

A study from the Spanish National Cancer Centre, Melchor Fernández Almagro 3, Madrid, Spain shows that: Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction.” This study was published in the 14 July 2015 issue of the journal “Cell Reportsby Prof. Maria, Povedano JM and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Idiopathic pulmonary fibrosis: Hyperoside, found in Drosera Rotundifolia and Prunella vulgaris (Common self-heal), increases TRF1 expression and ameliorates pulmonary fibrosis via upregulation of its target gene



Significance:

Given that: (1) Idiopathic pulmonary disease (IPD)/Idiopathic pulmonary fibrosis (IPF)  is a progressive degenerative disease of the lung, with debilitating consequences; (2) drugs that are currently used to treat IPF are ineffective; and (3) 6.8-16.3 per 100,000 persons suffer from  Idiopathic pulmonary disease, there is an urgent need to find: (i) a way to induce regeneration of lung cells in Idiopathic pulmonary fibrosis patients; (ii) side-effect-free natural product-based drug; and (iii) a way to effectively treat and cure IPF

A number of studies suggest that genes that promote telomere protection are mutated in Idiopathic pulmonary fibrosis. Prof. Maria’s research team has recently shown that deletion of telomeric repeat binding factor (TRF1) promotes pulmonary fibrosis.


Research Findings

Drosera Rotundifolia

Figure1. Hyperoside, found in Drosera Rotundifolia and Common self-heal, protects  against Idiopathic pulmonary fibrosis via up-regulation of TRF1

Hyperoside

This study suggests, for the first time, that Hyperoside, by increasing the expression of its target gene, it may increase the expression of TRF1. Thereby, it may: (1) alleviate DNA damage; (2) ameliorate telomere dysfunction and promote telomere function and integrity; and (3) inhibit the development and progression of pulmonary fibrosis.

Thus, pharmacological formulations encompassing Hyperoside or its analogues may be used to treat Idiopathic pulmonary fibrosis.


Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Natural product-based therapy for Idiopathic pulmonary fibrosis: Hyperoside, found in Drosera Rotundifolia and Prunella vulgaris (Common self-heal), increases TRF1 expression and ameliorates pulmonary fibrosis via upregulation of its target gene, 24/October/2015, 10.29 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org


Undisclosed information: How Hyperoside increases the expression of TRF1.

Amount: $300

satisfaction-guarantee

Results guaranteed if not refunded

# Research cooperation

Comments are closed.